journal article·2014-06

Surface functionalization of magnetic nanoparticles formed by self-associating hydrophobized oxidized dextrans

Shimon Farber, Diana E. Ickowicz, Kristie Melnik, Ira Yudovin-Farber, Daniel Recko, Arfaan Rampersaud, Abraham J. Domb

Journal of Nanoparticle Research· Volume 16· Issue 6
Publisher page

Abstract

Magnetic iron oxide nanoparticles surface covered with oleic acid layer followed by a second layer of hydrophobized oxidized dextran aldehyde were prepared and tested for physico-chemical properties and ligand- and cell-specific binding. It was demonstrated that oleic acid–iron oxide nanoparticles coated with an additional layer of hydrophobized oxidized dextran were dispersible in buffer solutions and possess surface aldehyde active groups available for further binding of ligands or markers via imine or amine bond formation. Hydrophobized dextrans were synthesized by periodate oxidation and conjugation of various alkanamines to oxidized dextran by imination. Physico-chemical properties, as separation using magnetic field, magnetite concentration, and particle diameter, of the prepared magnetic samples are reported. The biotin-binding protein, neutravidin, was coupled to the particle surface by a simple reductive amination procedure. The particles were used for specific cell separation with high specificity.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Biotin and Related Studies · Molecular Junctions and Nanostructures · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Amstad E et al (2009) Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5(11):1334–134210.1002/smll.200801328 ↗
2. Aumelas A et al (2007) Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems. Colloids Surf B 59(1):74–8010.1016/j.colsurfb.2007.04.021 ↗
3. Azzam T et al (2002) Polysaccharide–oligoamine based conjugates for gene delivery. J Med Chem 45(9):1817–182410.1021/jm0105528 ↗
4. Bautista MC et al (2004) Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging. Nanotechnology 15:S154–S15910.1088/0957-4484/15/4/008 ↗
5. Bogart LK et al (2012) Photothermal microscopy of the core of dextran-coated iron oxide nanoparticles during cell uptake. ACS Nano 6(7):5961–597110.1021/nn300868z ↗
6. Braun S, Marth C (2004) Circulating tumor cells in metastatic breast cancer—toward individualized treatment? N Engl J Med 351(8):824–82610.1056/NEJMe048163 ↗
7. Cobas JC, Sardina FJ (2003) Nuclear magnetic resonance data processing. MestRe-C: a software package for desktop computers. Concepts Magn Reson Part A 19(2):80–9610.1002/cmr.a.10089 ↗
8. Coe EM et al (1995) An investigation into the size of an iron dextran complex. J Inorg Biochem 60(2):149–15310.1016/0162-0134(95)00016-H ↗
9. Cole AJ et al (2011) Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 32(26):6291–630110.1016/j.biomaterials.2011.05.024 ↗
10. Daoud-Mahammed S et al (2007) Spontaneous association of hydrophobized dextran and poly-[beta]-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug. J Colloid Interface Sci 307(1):83–9310.1016/j.jcis.2006.10.072 ↗
11. Delben F et al (2006) Pullulans produced by strains of Cryphonectria parasitica. II. Nuclear magnetic resonance evidence. Carbohydr Polym 63(4):545–55410.1016/j.carbpol.2005.11.012 ↗
12. Euliss LE et al (2003) Cooperative assembly of magnetic nanoparticles and block copolypeptides in aqueous media. Nano Lett 3(11):1489–149310.1021/nl034472y ↗
13. Gonzales M, Krishnan KM (2007) Phase transfer of highly monodisperse iron oxide nanocrystals with Pluronic F127 for biomedical applications. J Magn Magn Mater 311(1):59–6210.1016/j.jmmm.2006.10.1150 ↗
14. Green NM (1990) Avidin and streptavidin. Methods Enzymol 184:51–6710.1016/0076-6879(90)84259-J ↗
15. Green NM et al (1970) Spectrophotometric determination of avidin and biotin. Methods in enzymology, vol 18, Part 1. Academic Press, San Diego, pp 418–42410.1016/0076-6879(71)18342-5 ↗
16. Griffiths SM et al (2011) Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Anal Chem 83(10):3778–378510.1021/ac200103x ↗
17. Hermanson GT (1996) Bioconjugate techniques. Academic Press, San Diego
18. Hsieh WJ et al (2012) In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. Int J Nanomed 7:2833–2842
19. Huang G et al (2009) A novel strategy for surface modification of superparamagnetic iron oxide nanoparticles for lung cancer imaging. J Mater Chem 19:6367–637210.1039/b902358e ↗
20. Huber D (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1(5):482–50110.1002/smll.200500006 ↗
21. Hyeon T et al (2001) Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 123(51):12798–1280110.1021/ja016812s ↗
22. Kalyanaraman R et al (1998) Synthesis and consolidation of iron nanopowders. Nanostruct Mater 10(8):1379–139210.1016/S0965-9773(99)00017-3 ↗
23. Kievit FM et al (2009) PEI–PEG–chitosan copolymer coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv Funct Mater 19(14):2244–225110.1002/adfm.200801844 ↗
24. Knight B et al (1999) Comparison of the core size distribution in iron dextran complexes using Mossbauer spectroscopy and X-ray diffraction. J Inorg Biochem 73(4):227–23310.1016/S0162-0134(99)00020-3 ↗
25. Kumar N et al (2002) Molecular mass distribution of polycations and dextrans by high-performance size exclusion chromatography. Polym Adv Technol 13(10–12):1071–107710.1002/pat.245 ↗
26. Laurent S et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–211010.1021/cr068445e ↗
27. Lewin M et al (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18(4):410–41410.1038/74464 ↗
28. Li J et al (2011) Carboxymethylated dextran-coated magnetic iron oxide nanoparticles for regenerable bioseparation. J Nanosci Nanotechnol 11(11):10187–1019210.1166/jnn.2011.5002 ↗
29. Lopez-Lopez MT et al (2005) Stability and magnetic characterization of oleate-covered magnetite ferrofluids in different nonpolar carriers. J Colloid Interface Sci 291(1):144–15110.1016/j.jcis.2005.04.099 ↗
30. Molday RS (1982) Magnetic iron-dextran microspheres. Canadian Patents and Development Limited, Ottawa, pp 1–21
31. Morales MA et al (2005) Magnetic studies of iron oxide nanoparticles coated with oleic acid and Pluronic (R) block copolymer. J Appl Phys 97(10):10Q90510.1063/1.1850855 ↗
32. Nie LM et al (2007) Detection of foreign body using fast thermoacoustic tomography with a multielement linear transducer array. Appl Phys Lett 90(17):17410910.1063/1.2732824 ↗
33. Pal S et al (2009) Synthesis and magnetic properties of gold coated iron oxide nanoparticles. J Appl Phys 105(7):07B50410.1063/1.3059607 ↗
34. Rodrigues MiR (2005) Hydrophobic derivatives of dextran polysaccharide: characterization and properties. J Carbohydr Chem 24(7):733–74410.1080/07328300500261007 ↗
35. Rouzes C et al (2002) Surface activity and emulsification properties of hydrophobically modified dextrans. J Colloid Interface Sci 253(1):217–22310.1006/jcis.2002.8357 ↗
36. Shen L et al (1999a) Aqueous magnetic fluids stabilized by surfactant bilayers. J Magn Magn Mater 194(1–3):37–4410.1016/S0304-8853(98)00587-3 ↗
37. Shen L et al (1999b) Bilayer surfactant stabilized magnetic fields: synthesis and interactions at interfaces. Langmuir 15:447–45310.1021/la9807661 ↗
38. Shukla N et al (2003) FTIR study of surfactant bonding to FePt nanoparticles. J Magn Magn Mater 266:178–18410.1016/S0304-8853(03)00469-4 ↗
39. Smith PK et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76–8510.1016/0003-2697(85)90442-7 ↗
40. Tassa C et al (2011) Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44(10):842–85210.1021/ar200084x ↗
41. Vasseur S et al (2006) Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermia. J Magn Magn Mater 302(2):315–32010.1016/j.jmmm.2005.09.026 ↗
42. Woo K, Hong J (2005) Surface modification of hydrophobic iron oxide nanoparticles for clinical applications. IEEE Trans Magn 41(10):4137–413910.1109/TMAG.2005.855343 ↗
43. Yu WW et al (2006) Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 17(17):4483–448710.1088/0957-4484/17/17/033 ↗
44. Zhang L et al (2006) Oleic acid coating on the monodisperse magnetite nanoparticles. Appl Surf Sci 253(5):2611–261710.1016/j.apsusc.2006.05.023 ↗
45. Zhao H, Heindel ND (1991) Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm Res 8(3):400–40210.1023/A:1015866104055 ↗